Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hilger

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
The British Journal of Ophthalmology|January 26, 2012
Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinationsHenrike Westekemper, Michael Freistuehler, Gerasimos Anastassiou, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 13, 2017
Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentratesP L F Giangrande, F Peyvandi, B O'Mahony, et al.
Craniomaxillofacial Trauma & Reconstruction|November 15, 2024
Premorbid Incidence of Mental Health and Substance Abuse Disorders in Facial Trauma PatientsAdeeb Derakhshan, Hunter Archibald, Harley S Dresner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2014
Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentratesP Giangrande, R Seitz, M E Behr-Gross, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 11, 2009
Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysisR A Hilger, H Richly, M Grubert, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|July 9, 2009
Microbial methane oxidation processes and technologies for mitigation of landfill gas emissionsCharlotte Scheutz, Peter Kjeldsen, Jean E Bogner, et al.
British Journal of Cancer|December 22, 1999
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell linesU Vanhoefer, M R Müller, R A Hilger, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agentsH Westekemper, M Freistuehler, G Anastassiou, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumorsD Strumberg, D Voliotis, J G Moeller, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 11, 2009
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumorsM M Henke, H Richly, A Drescher, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
The British Journal of Ophthalmology|January 26, 2012
Chemosensitivity of conjunctival melanoma cell lines to single chemotherapeutic agents and combinationsHenrike Westekemper, Michael Freistuehler, Gerasimos Anastassiou, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 13, 2017
Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentratesP L F Giangrande, F Peyvandi, B O'Mahony, et al.
Craniomaxillofacial Trauma & Reconstruction|November 15, 2024
Premorbid Incidence of Mental Health and Substance Abuse Disorders in Facial Trauma PatientsAdeeb Derakhshan, Hunter Archibald, Harley S Dresner, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2014
Kreuth III: European consensus proposals for treatment of haemophilia with coagulation factor concentratesP Giangrande, R Seitz, M E Behr-Gross, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 11, 2009
Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysisR A Hilger, H Richly, M Grubert, et al.
Waste Management & Research : the Journal of the International Solid Wastes and Public Cleansing Association, ISWA|July 9, 2009
Microbial methane oxidation processes and technologies for mitigation of landfill gas emissionsCharlotte Scheutz, Peter Kjeldsen, Jean E Bogner, et al.
British Journal of Cancer|December 22, 1999
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell linesU Vanhoefer, M R Müller, R A Hilger, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2010
Chemosensitivity of conjunctival melanoma cell lines to chemotherapeutic agentsH Westekemper, M Freistuehler, G Anastassiou, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 31, 2002
Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumorsD Strumberg, D Voliotis, J G Moeller, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 11, 2009
Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumorsM M Henke, H Richly, A Drescher, et al.
Pageof 15